Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (346)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Osimertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Osimertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Durvalumab	Anti-PD-L1 mAb	Solid Tumour
Molecule Durvalumab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-PD-L1 mAb
Enzalutamide	Antiandrogen	Solid Tumour (Prostate)
Molecule Enzalutamide Therapeutic Category Hormonal Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Antiandrogen
Abemaciclib	CDK Inhibitor	Solid Tumour
Molecule Abemaciclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Trastuzumab Deruxtecan	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Trastuzumab Deruxtecan Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Ribociclib	CDK Inhibitor	Solid Tumour
Molecule Ribociclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Atezolizumab	Anti-PD-L1 mAb	Solid Tumour
Molecule Atezolizumab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-PD-L1 mAb
Pertuzumab	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Pertuzumab Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Palbociclib	CDK Inhibitor	Solid Tumour
Molecule Palbociclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Apalutamide	Antiandrogen	Solid Tumour (Prostate)
Molecule Apalutamide Therapeutic Category Hormonal Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Antiandrogen
Olaparib	PARP Inhibitor	Solid Tumour
Molecule Olaparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Ipilimumab	Anti-CTLA-4 mAb	Solid Tumour
Molecule Ipilimumab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-CTLA-4 mAb

Osimertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Durvalumab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-PD-L1 mAb
Enzalutamide Hormonal Therapy
Therapeutic Category Hormonal Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Antiandrogen
Abemaciclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Trastuzumab Deruxtecan Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Ribociclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Atezolizumab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-PD-L1 mAb
Pertuzumab Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Palbociclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Apalutamide Hormonal Therapy
Therapeutic Category Hormonal Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Antiandrogen
Olaparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Ipilimumab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-CTLA-4 mAb

‹ 1 2 3 … 29 ›

Product Range

Company

Global Network

Products

All Products (346)

Osimertinib

Durvalumab

Enzalutamide

Abemaciclib

Trastuzumab Deruxtecan

Ribociclib

Atezolizumab

Pertuzumab

Palbociclib

Apalutamide

Olaparib

Ipilimumab

Osimertinib

Durvalumab

Enzalutamide

Abemaciclib

Trastuzumab Deruxtecan

Ribociclib

Atezolizumab

Pertuzumab

Palbociclib

Apalutamide

Olaparib

Ipilimumab